Holen Sie sich die Stockscreener-App
33.69
4.59%
-1.62
Handel nachbörslich:
33.70
0.01
+0.03%
Schlusskurs vom Vortag:
$35.31
Offen:
$35.56
24-Stunden-Volumen:
16,379
Relative Volume:
0.60
Marktkapitalisierung:
$294.49M
Einnahmen:
$64.99M
Nettoeinkommen (Verlust:
$-4.30M
KGV:
-64.79
EPS:
-0.52
Netto-Cashflow:
$-3.51M
1W Leistung:
-3.80%
1M Leistung:
-0.91%
6M Leistung:
-0.80%
1J Leistung:
-10.28%
1-Tages-Spanne:
$33.69
$35.56
1-Wochen-Bereich:
$33.69
$35.90
52-Wochen-Spanne:
$26.00
$39.98
Sanara Medtech Inc Stock (SMTI) Company Profile
Firmenname
Sanara Medtech Inc
Sektor
Telefon
817-529-2300
Adresse
1200 SUMMIT AVE, FORT WORTH
Vergleichen Sie SMTI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
33.69 | 294.49M | 64.99M | -4.30M | -3.51M | -0.52 |
|
ISRG
Intuitive Surgical Inc
|
591.79 | 211.07B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.43 | 65.30B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
90.31 | 44.67B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.69 | 34.04B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
88.48 | 17.62B | 3.90B | 392.30M | 288.10M | 1.95 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-05-20 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc Aktie (SMTI) Neueste Nachrichten
Cantor Fitzgerald lifts Sanara MedTech target to $46, retains Overweight - MSN
Sanara MedTech Inc. Announces 2019 Results - ACCESS Newswire
Janney Montgomery Scott LLC Has $874,000 Holdings in Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
Fifth Third Bancorp Makes New Investment in Sanara MedTech Inc. (NASDAQ:SMTI) - MarketBeat
JPMorgan Chase & Co. Boosts Stake in Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
Sanara MedTech expects Q4 revenue in the range of $25.7M to $26.2M - MSN
Sanara MedTech: A Promising Growth Story At An Attractive Valuation - Seeking Alpha
(SMTI) Investment Report - Stock Traders Daily
FY2024 EPS Estimates for Sanara MedTech Increased by Analyst - MarketBeat
Cantor Fitzgerald Estimates Sanara MedTech FY2024 Earnings - Defense World
FY2024 EPS Estimate for Sanara MedTech Increased by Analyst - Defense World
HC Wainwright Forecasts Stronger Earnings for Sanara MedTech - MarketBeat
Sanara MedTech Inc. Announces Pricing of Public Offering - ACCESS Newswire
Sanara MedTech Inc. Announces Closing of $31.6 Million Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - accessnewswire.com
Sanara MedTech’s (SMTI) Buy Rating Reiterated at HC Wainwright - Defense World
Sanara MedTech Inc. Announces the Commercial Launch of Two New Innovative Extracellular Matrix Products from Cook Biotech Inc. - ACCESS Newswire
Sanara MedTech Inc. Announces the Execution of a New License Agreement with Rochal Industries, LLC - ACCESS Newswire
Financial Comparison: Sanara MedTech (NASDAQ:SMTI) vs. ReWalk Robotics (NASDAQ:LFWD) - Defense World
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc. - The Manila Times
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, - GlobeNewswire
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution… - Informazione.it
Cantor Fitzgerald Comments on Sanara MedTech FY2025 Earnings - Defense World
Cantor Fitzgerald Estimates Sanara MedTech FY2025 Earnings - MarketBeat
HC Wainwright Reaffirms "Buy" Rating for Sanara MedTech (NASDAQ:SMTI) - MarketBeat
Insiders were the key beneficiaries as Sanara MedTech Inc.'s (NASDAQ:SMTI) market cap rises to US$297m - Simply Wall St
Sanara MedTech expands executive leadership team - Medical Buyer
Barclays PLC Has $174,000 Position in Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
Sanara MedTech Inc. Posts Strong Growth in Q4 and Full Year 2024 Results - Defense World
Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with Biomimetic Innovations Ltd - Defense World
Sanara MedTech Strengthens Leadership with New CFO Appointment - TipRanks
Sanara MedTech Secures U.S. Rights for OsStic - TipRanks
Cantor Fitzgerald lifts Sanara MedTech target to $46, retains Overweight By Investing.com - Investing.com South Africa
Cantor Fitzgerald Reiterates Overweight Rating for Sanara MedTech (NASDAQ:SMTI) - MarketBeat
Sanara MedTech expects Q4 revenue to increase 45%- 48% - Medical Buyer
Texas medtech firm Sanara invests €8m in Irish breakthrough bone adhesive company - Business Post
Sanara MedTech reshapes executive team with new CFO and CAO - MSN
SMTISanara MedTech Inc. Latest Stock News & Market Updates - StockTitan
Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024 - The Manila Times
Sanara MedTech reshapes executive team with new CFO and CAO By Investing.com - Investing.com Canada
Sanara MedTech Inc. Announces Exclusive License and - GlobeNewswire
Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments - GlobeNewswire
Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd - Marketscreener.com
Sanara MedTech Inc. Announces the Execution of an Exclusive License and Distribution Agreement with Biomimetic Innovations Ltd - Marketscreener.com
Sanara MedTech Inc. Appoints Michael McNeil as Chief Accounting Officer and Chief Administrative Officer - Marketscreener.com
Sanara MedTech Reports Record Q4: Revenue Surges 48% on Strong Surgical Product Sales - StockTitan
How to Take Advantage of moves in (SMTI) - Stock Traders Daily
Barclays PLC Acquires 4,376 Shares of Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
Geode Capital Management LLC Grows Position in Sanara MedTech Inc. (NASDAQ:SMTI) - Defense World
How the (SMTI) price action is used to our Advantage - Stock Traders Daily
Sanara MedTech Inc. (NASDAQ:SMTI) Stake Boosted by State Street Corp - Defense World
Finanzdaten der Sanara Medtech Inc-Aktie (SMTI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):